Yes, gestational trophoblastic cancers originate from placental tissue
Gestational trophoblastic disease (GTD) and its malignant forms—collectively called gestational trophoblastic neoplasia (GTN)—arise directly from trophoblastic cells, which are the cells that form the placenta during pregnancy. 1, 2
Origin and Cell Types
The cancer develops from different types of placental trophoblast cells:
Villous trophoblast origin: Choriocarcinoma and invasive moles develop from villous trophoblast (cytotrophoblast and syncytiotrophoblast), which are the cells that form the finger-like projections of the placenta 2
Extravillous trophoblast origin: Placental site trophoblastic tumor (PSTT) and epithelioid trophoblastic tumor (ETT) arise from intermediate trophoblast cells at the placental implantation site 2
How These Cancers Develop
GTN can arise from several pregnancy scenarios:
After molar pregnancy (50%): Most commonly follows abnormal fertilization resulting in hydatidiform mole, where 15-20% of complete moles progress to GTN 2
After normal pregnancy (25%): Can develop following term or preterm delivery 2
After miscarriage or ectopic pregnancy (25%): May arise from tubal pregnancy or spontaneous abortion 2
Key Distinguishing Features
What makes these cancers unique is their gestational origin—meaning the tumor tissue is genetically distinct from the mother. The cancer cells contain paternal genetic material from the pregnancy, not maternal DNA mutations 3, 4. This is fundamentally different from other cancers that arise from the patient's own cells.
Important caveat: Recent research suggests gestational choriocarcinoma likely arises from aberrations in methylation patterns during early placental development rather than from DNA driver mutations 3. The tumor cells retain characteristics of early first-trimester trophoblast—naturally invasive, rapidly dividing cells—which explains both their aggressive behavior and their remarkable sensitivity to chemotherapy.
The diagnosis can be confirmed through genetic analysis (STR analysis) comparing tumor tissue to maternal tissue, which demonstrates the presence of paternal chromosomal material, definitively proving placental origin 4.